Join
Live feed
·
NEWSReleasevia Quantisnow
Telomir Pharmaceuticals Inc. logo

Telomir Pharmaceuticals Reports Peer-Reviewed Publication of Telomir-Zn Data Demonstrating Improved Survival and Multiple Endpoint Benefits in Wilson's Disease

ByQuantisnow·Wall Street's wire, on your screen.
TELO· Telomir Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TELO (Telomir Pharmaceuticals Inc.) and more on Quantisnow.